Mednax (MD) PT Lowered to $48 at Mizuho Securities
Tweet
Share
E-mailGet Alerts MD Hot Sheet
Price: $26.66 +1.64%
Rating Summary:
6 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
6 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Mizuho Securities lowered its price target on Mednax (NYSE: MD) to $48.00 (from $62.00) while maintaining a Neutral rating.
Analyst Ann Hynes believes the company decision to step away from anesthesiology acquisitions in the NT will like mean headwinds are like to remain in the NT.
FY 2018 EPS estimate falls from $4.00 to $3.54 and FY 2019 EPS estimate is for $3.80.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
- MiniMed Group (MMED) PT Raised to $28 at BTIG
- salesforce.com (CRM) PT Raised to $300 at TD Cowen
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
